United Kingdom· GB-APID-43811011000001103
PiaSky 340mg/2ml solution for injection vials
A crovalimab product containing crovalimab, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Crovalimab is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AJ07 (crovalimab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Crovalimab · ATC L04AJ07
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Crovalimab
- Manufacturer
- Roche Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AJ07
- ATC class
- Crovalimab
- Defined daily dose
- 24.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7613326079341
- gtin07613326079341
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Crovalimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumPiasky 340 mgRoche Registration
- SwitzerlandPiasky 340 mg/ 2 ml, Injektions-/InfusionslösungRoche Pharma (Schweiz) AG
- CzechiaPIASKYRoche Registration GmbH, Grenzach-Wyhlen
- SpainPIASKY 340 MG SOLUCION INYECTABLE Y PARA PERFUSIONRoche Registration Gmbh
- FinlandPiaskyRoche Registration GmbH
- IrelandPiaskyRoche Registration GmbH
- IcelandPiaskyRoche Registration GmbH*
- Japanクロバリマブ（遺伝子組換え）中外製薬
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Piasky
- Liechtenstein · Piasky
- Norway · Piasky
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56b8e822-0644-4b40-9c0e-163af0406120 GET /v1/drugs/56b8e822-0644-4b40-9c0e-163af0406120?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43811011000001103",
"desc": "PiaSky 340mg/2ml solution for injection vials (Roche Products Ltd)",
"form": "Solution for injection",
"vpid": "43907611000001107",
"source": "dmd",
"vtm_id": "43895311000001102",
"strength": "170 mg",
"substance": "Crovalimab",
"ingredient": "Crovalimab",
"supplier_code": "2085201000001100"
}See everything about crovalimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.